NDA Group is a world leading regulatory, drug development and medical device consultancy. We have a dedicated team of over 150 consultants supported by an expert network and a specialist Advisory Board many of whom are ex- European and US Agency staff.
We support life science companies all over the world and across all phases of development, from pre-clinical to post marketing, to meet the needs and requirements of regulators and payers alike.
Working together with our clients to address key strategic regulatory and reimbursement challenges, our goal is to help streamline drug development to accelerate patient access to important medical therapies. Our scientific expertise covers all major therapeutic areas.
NDA Group supported over 40% of the new medicinal products that were approved in the EU over the last five years. www.ndareg.com